Skip to content
i2E
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Menu
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Search

BioSummit set in Oklahoma City

Get in Touch

By Journal Record Staff

Courtesy of The Journal Record

OKLAHOMA CITY – The 2014 BioSummit is scheduled March 26 at the Skirvin Hilton Hotel in Oklahoma City.

Presented by the Oklahoma Bioscience Association, the BioSummit will include experts in scientific discovery, commercialization and funding who will share their insights with scientists and entrepreneurs from across the state.

Topics explored at the BioSummit presented by the Oklahoma Biosciences Association will include funding fundamentals, partners and exit strategies, drug repurposing, positioning for early-stage investments, key elements of marketing and interacting with the bio industry.

“Our researchers and bioscience entrepreneurs will benefit greatly from the experiences of those who have been through the drug discovery and commercialization process before,” said Scott Meacham, president and CEO of i2E Inc., which manages the Oklahoma Bioscience Association.

Speakers will include Scott Meacham, president and CEO, i2E, Inc., William Paiva, managing director of the Oklahoma Life Science Fund; Von Allen, director of development at the University of Oklahoma and the Stephenson Cancer Center; Clayton Duncan, CEO at Accele Biopharma; Doug Branch, director, PhillipsMurrah, Dennis Shafer, president and CEO, Altheus Therapeutics; and William A. Hagstrom president and CEO, Crescendo Bioscience, Elaine Hamm, Director, Proof of Concept Center and Venture Advisor, i2E, Inc. and Vikas Sharma, Director, Business Development, Rexahn Pharmaceuticals & former Manager, Business Development, MedImmune.

Awards to be presented at BioSummit include Hall of Fame Leadership Award, Researcher Recognition Award, Community Recognition Award and Innovation Recognition Award.

For information, visit www.i2E.org or www.okbio.org.

Click here to read the article at the Journal Record website (subscription required).

 

Author

  • admin admin

More News

Loading...
Black doctor smiling with stethoscope
Blog, i2E
02.09.23

Titan Intake Automates Patient Referrals to Accelerate Care

Read more
man and woman reviewing paperwork at a table
Blog, i2E, News
01.10.23

Stories of Oklahoma Innovation: Building a Startup

Read more
woman in lab conducting a study
Blog, i2E
12.13.22

Bayesic Technologies Improves Effectiveness and Efficiency of Data Analysis in Healthcare

Read more
Bison grazing fields
Blog
11.30.22

Bison Underground Merges Nature, Science, and Technology to Tackle Climate Change

Read more
African American family sitting on couch reading and chatting
Blog, E3, i2E
11.22.22

Fokes Connects Families, Caregivers and Care Agencies for Smoother Communications and Care 

Read more
i2e blog post graphic
Blog, News
11.03.22

Introducing: Stories of Oklahoma Innovation

Read more
Default Featured Image
OKBio
06.28.22

Oklahoma Grown! i2E Invests in BIO startups

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma Medical Research Foundation BIO

Read more
Default Featured Image
OKBio
06.13.22

Moleculera Labs BIO

Read more
Default Featured Image
OKBio
06.13.22

University of Oklahoma Health Sciences Center BIO

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma State University BIO

Read more
Default Featured Image
OKBio
06.13.22

ECHO Investment Capital BIO

Read more
i2E

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
+1 (405) 235.2305

Tulsa Office

100 S. Cincinnati Ave – Suite 514
Tulsa, OK 74103
+1 (918) 582.5592

  • Client Portfolio
  • About Us
  • Media
  • Events
  • Contact
  • Resources

© 2022 i2E Privacy Policy

Follow us:

Facebook Twitter Linkedin

Programs

  • E3
  • ACT Tulsa
  • Love's Entrepreneur's Cup
  • OKBio
  • Client Portfolio

Services

  • Access to Funding
  • Venture Advisory Services
  • Contact
  • About
  • Our Values
  • Our Team
  • Board of Directors
  • Corporate Partners
  • Media
i2E